Goldman Sachs Gains Confidence In Market Rebound, Upgrades GE Healthcare Amid China Recovery Hopes
1. Trump announced tariffs on imports from Mexico, Canada, and China. 2. China retaliated with tariffs and sanctions on U.S. goods. 3. Goldman Sachs upgraded GEHC from Neutral to Buy, target raised to $100. 4. China's market for GEHC shows signs of stabilizing and growth. 5. GEHC's growth may lag due to sustained headwinds in the China market.